Literature DB >> 1356491

MDMA (Ecstasy) precipitation of panic disorder.

S Pallanti1, D Mazzi.   

Abstract

The authors describe three patients whose panic disorder began during recreational use of MDMA (Ecstasy) and was subsequently complicated by agoraphobic avoidance that continued autonomously after cessation of the drug. Their panic disorder responded well to serotoninergic antidepressant drugs. Theoretical and practical implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356491     DOI: 10.1016/0006-3223(92)90145-p

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

Review 2.  Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Authors:  Stephanie C Licata; Perry F Renshaw
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 3.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 4.  Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Authors:  U D McCann; S O Slate; G A Ricaurte
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

5.  Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.

Authors:  Jörg Daumann; Gernot Hensen; Bastian Thimm; Markus Rezk; Bianca Till; Euphrosyne Gouzoulis-Mayfrank
Journal:  Psychopharmacology (Berl)       Date:  2004-01-14       Impact factor: 4.530

6.  Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing.

Authors:  P J Hooft; H P van de Voorde
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

Review 7.  3,4-methylenedioxymethamphetamine (MDMA): a review.

Authors:  G O'Leary; J Nargiso; R D Weiss
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 8.081

Review 8.  The Health Effect of Psychostimulants: A Literature Review.

Authors:  Thierry Favrod-Coune; Barbara Broers
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-22

9.  Crime and Violence among MDMA Users in the United States.

Authors:  Michael G Vaughn; Christopher P Salas-Wright; Matt DeLisi; Brian E Perron; David Cordova
Journal:  AIMS Public Health       Date:  2015-03-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.